Mr. Speaker, the WTO drug patent ruling is yet another example of the government wasting valuable time and money on a senseless dispute before the WTO. Canada's own negotiators involved with the TRIPS agreement said in May that this was an open and shut case. Yet the minister went ahead with an appeal that he knew would be lost when his priority should have been to inform Canadian consumers of the impact of the WTO decision. Why?
In the House of Commons on September 20th, 2000. See this statement in context.